Arkolith/Insider Trading/GLSI/Form 4/A

Patel Snehal

CEO and CFO, Director, 10% OwnerGreenwich LifeSciences, Inc. (GLSI) · full profile →Form 4/A · filed Mar 7, 2024
Net Buying
Open-Market Buys
$44K
Open-Market Sells
$0
Net Open-Market Flow
$44K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 5, 2024Buy(P)4K$12.49$44K5.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001493152-24-009164) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML